LAURIE J OLSON

CIK 1553231 · Executive Vice President · last filed 2024-05-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.09M

Companies

3

Total Filings

71

Lifetime Open-Market Net

-$4.82M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QTRX Director 13,738 $3.10 $42.6K -$145.2K 10 2024-05-14
Karuna Therapeutics, Inc. (KRTX) Delisted Director 0 $329.83 $0 -$1.88M 15 2024-03-18
PFE Executive Vice President 78,201 $26.21 $2.05M -$2.79M 46 2018-08-14

Recent Filings · Page 7 of 8

71 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2013-06-18 PFE Grant (A) $0 EDGAR
2013-06-03 PFE Grant (A) $0 EDGAR
2013-05-16 PFE Grant (A) $0 EDGAR
2013-05-01 PFE Grant (A) $0 EDGAR
2013-04-17 PFE Grant (A) $0 EDGAR
2013-04-01 PFE Grant (A) $0 EDGAR
2013-03-18 PFE Grant (A) $0 EDGAR
2013-03-04 PFE Mixed +14,682 -$90.3K EDGAR
2013-02-26 PFE Tax (F) −2,197 -$59.0K EDGAR
2013-01-03 PFE Tax (F) −1,960 -$49.2K EDGAR
Showing 6170 of 71
Page 7 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.